What is Schott Pharma analytics?
SCHOTT Pharma Analytics. SCHOTT pharma services offers specialized analytical testing services for pharmaceutical packaging covering the most challenging packaging issues. Glass delamination / chemical durability testing USP <1660>, EP 3.2.1.
What does the Schott company do?
SCHOTT AG manufactures glass products. The Company offers glass for ceramic cooktops, solar power modules, metal enclosures, color filters, syringers, and other products. SCHOTT serves household appliances, solar power, pharmaceuticals, electronics, optics, transportation, automotive, and architecture industries worldwide.
How much of scpharmaceuticals stock are insiders buying?
In the past three months, scPharmaceuticals insiders have bought more of their company's stock than they have sold. Specifically, they have bought $59,150.00 in company stock and sold $0.00 in company stock. Only 3.71% of the stock of scPharmaceuticals is held by insiders. 58.64% of the stock of scPharmaceuticals is held by institutions.
What are the best value pharmaceutical stocks to buy?
Best Value Pharmaceutical Stocks Price ($) Market Cap ($B) 12-Month Trailing P/E Ratio Emergent Biosolutions Inc. ( EBS) 63.91 3.4 8.9 Sanofi SA ( SNY) 52.06 130.2 10.8 Ironwood Pharmaceuticals, Inc. ( IRWD) 11.46 1.9 12.9
Is Schott publicly traded?
As of July 1st, the Mainz-based company previously known as SCHOTT GLAS is a stock corporation (AG). With its entry into the Mainz trade register as "SCHOTT AG," the conversion process is now complete.
What is Schott AG stock symbol?
📉 SCHOTT SOLAR AG Share Price - S9S Share Price.
Who owns Schott Ceran?
the Carl Zeiss FoundationWith more than 15,500 employees at production sites and sales offices in 33 countries, the group has a global presence. In the 2016/2017 fiscal year, SCHOTT generated sales of EUR 2.05 billion. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation.
Where is Schott AG located?
Mainz, GermanySchott AG is a German multinational glass company specializing in the manufacture of glass and glass-ceramics. Headquartered in Mainz, Germany, it is owned by the Carl Zeiss Foundation.
SCHOTT Pharma Analytics
SCHOTT pharma services offers specialized analytical testing services for pharmaceutical packaging covering the most challenging packaging issues.
Solutions tailored to the user's needs
SCHOTT designs glass primary packaging solutions tailored to the user's needs. The core of our expertise comprises a large range of pharmaceutical containers made from tubular borosilicate glass. The product portfolio includes syringes, vials, cartridges and ampoules, which are safe and easy to use for people around the world.
SCHOTT Pharma Online Shop
Our Online Shop provides an easy and fast access to small volume and high quality pharmaceutical packaging solutions. With standardized and pre-tested products we ensure fast delivery times. Our customer care helps you in case you need a product recommendation to safely package your drug. Open at all times. Quality at all times.
SCHOTT Pharma Analytics
SCHOTT pharma services offers specialized analytical testing services for pharmaceutical packaging covering the most challenging packaging issues.
Solutions tailored to the user's needs
SCHOTT designs glass primary packaging solutions tailored to the user's needs. The core of our expertise comprises a large range of pharmaceutical containers made from tubular borosilicate glass. The product portfolio includes syringes, vials, cartridges and ampoules, which are safe and easy to use for people around the world.
SCHOTT Pharma Online Shop
Our Online Shop provides an easy and fast access to small volume and high quality pharmaceutical packaging solutions. With standardized and pre-tested products we ensure fast delivery times. Our customer care helps you in case you need a product recommendation to safely package your drug. Open at all times. Quality at all times.
About scPharmaceuticals
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting.
scPharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for scPharmaceuticals in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" scPharmaceuticals stock. View analyst ratings for scPharmaceuticals or view top-rated stocks.
What is scpharmaceuticals 2021?
(Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2 at 3:30 EDT. A live webcast of the presentation can be accessed under “News and Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com. About scPharmaceuticals scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com. Katherine TaudvinscPharmaceuticals Inc., [email protected] Investors:Hans VitzthumLifeSci Advisors, [email protected]
What is the increase in expenses for scpharmaceuticals?
scPharmaceuticals reported a net loss of $32.2 million for the year ended December 31, 2020, compared to $33.0 million for the comparable period in 2019.
What is SCPH 2021?
(Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24 at 11:20 EDT. A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com. About scPharmaceuticals scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com. Katherine TaudvinscPharmaceuticals Inc., [email protected] Investors:Hans VitzthumLifeSci Advisors, [email protected]
How much will scpharmaceuticals lose in 2021?
scPharmaceuticals reported a net loss of $7.1 million for the first quarter of 2021, compared to $7.1 million for the comparable period in 2020.
What was the decrease in research and development expenses for the quarter ended December 31, 2020?
The decrease in research and development expenses for the quarter ended December 31, 2020 was primarily due to a decrease in device and pharmaceutical development activities. General and administrative expenses were $3.4 million for the fourth quarter of 2020, compared to $2.1 million for the comparable period in 2019.
What are the best pharmaceutical stocks to buy?
Best Value Pharmaceutical Stocks 1 Emergent BioSolutions Inc.: Emergent BioSolutions sells products such as anthrax vaccines, NARCAN Nasal Spray (opioid overdose), and ACAM2000 (smallpox vaccine). During the pandemic, Emergent partnered with the government to produce COVID-19 vaccines. The company reported a sharp increase in revenue in Q1 2021, helping it to swing from a loss a year ago to a profit in the current quarter. 2 2 Sanofi SA.: Sanofi, based in France, owns pharmaceutical, vaccine, and consumer healthcare businesses. Its products treat a wide range of diseases, including rheumatoid arthritis, cancer, diabetes, cardiovascular diseases, and rare blood disorders. 3 Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals develops drugs for gastrointestinal and cardiovascular diseases. In March, chief executive officer (CEO) Mark Mallon stepped down and was replaced by Thomas McCourt. 3 4
What is the pharmaceutical industry?
The pharmaceutical industry is made of companies that research, develop, make, and sell drugs and treatments used to treat or eradicate diseases, and vaccinate people. This includes some of the largest and best-known companies in the world, such as Pfizer Inc. ( PFE ), Merck & Co. Inc. ( MRK ), and AbbVie Inc. ( ABBV ).
Who is Rakesh Sharma?
Rakesh Sharma is a writer with 8+ years of experience about the intersection between technology and business. Rakesh is an expert in investing, business, blockchain, and cryptocurrencies. Learn about our editorial policies. Rakesh Sharma. Updated Jun 15, 2021.
What is Redhill Biopharma?
Redhill Biopharma Ltd.: Redhill Biopharma is a specialty biopharmaceutical company. It develops products primarily used to treat diseases and medical conditions for gastrointenstines and for infections. EPS was negative for the most recent quarter so it does not apply to the EPS growth part of the table above.
